Skip to content

An exploratory pilot randomised controlled trial for the effects of strength training with different intensities on Duchenne muscular dystrophy

An exploratory pilot randomised controlled trial for the effects of strength training with different intensities on Duchenne muscular dystrophy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025075
Enrollment
Unknown
Registered
2019-08-10
Start date
2019-08-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne muscular dystrophy

Interventions

Non-resistance active exercise training group:Active anti-gravity muscle strength training
Low intensity resistance exercise training group:Low intensity resistance muscle strength training
Medium intensity resistance exercise training group:Medium intensity resistance muscle strength training

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
5 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Male patients with the age of 5 to 10 years old, who can walk more than 10 meters independently and continuously. 2. The clinical symptoms, signs and laboratory results of the patients were in accordance with the diagnostic criteria of DMD. 3. The diagnosis of the patients should be established by either DNA testing or muscle biopsy, or both. 4. The patients have been receiving regular drug treatment and achieved stable effect. 5. The patients have not received regular muscle strength training intervention before.

Exclusion criteria

Exclusion criteria: 1. The patients have received surgery recently. 2. The patients have some other diseases which can affect their ability of activity. 3. The patients have cardiomyopathy with clinical symptoms. 4. The patients have the disturbance of understanding, and are unable to cooperate with the assessment and training. 5. The patients are unable to cooperate with the follow-up.

Design outcomes

Primary

MeasureTime frame
muscle strength;ranges of motion;6-min walk test;timed function test;Motor Function Measure for Neuromuscular disorders;North Star Ambulatory Assessment;Vignos classification for lower limb function;Brooke classification for upper limb function;

Countries

China

Contacts

Public ContactWenzhu Li

Peking University First Hospital

bamboolna@163.com+86 10 83575162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026